# Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis

> **NCT06184685** · PHASE2 · COMPLETED · sponsor: **Thammasat University** · enrollment: 87 (actual)

## Conditions studied

- Primary Knee Osteoarthritis

## Interventions

- **DRUG:** Sahasthara Microemulsion
- **DRUG:** Diclofenac Microemulsion

## Key facts

- **NCT ID:** NCT06184685
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-20
- **Primary completion:** 2021-11-17
- **Final completion:** 2021-12-08
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2023-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06184685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06184685, "Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06184685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*